[HTML][HTML] Voriconazole exposure and risk of cutaneous squamous cell carcinoma, Aspergillus colonization, invasive aspergillosis and death in lung transplant …

M Mansh, M Binstock, K Williams, F Hafeez… - American Journal of …, 2016 - Elsevier
Voriconazole is a triazole antifungal used to prevent and treat invasive fungal infections after
lung transplantation, but it has been associated with an increased risk of developing
cutaneous squamous cell carcinoma (SCC). Despite widespread use, there are no clear
guidelines for optimal prophylactic regimens that balance the competing risks and benefits.
We conducted a retrospective cohort study of all lung transplant recipients at the University
of California, San Francisco, who were transplanted between October 1991 and December …